Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Agios Pharmaceuticals Inc’s stock clocked out at $31.68, up 1.54% from its previous closing price of $31.20. In other words, the price has increased by $1.54 from its previous closing price. On the day, 0.76 million shares were traded. AGIO stock price reached its highest trading level at $31.74 during the session, while it also had its lowest trading level at $31.0.
Ratios:
To gain a deeper understanding of AGIO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.56 and its Current Ratio is at 11.90. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on February 24, 2025, initiated with a Buy rating and assigned the stock a target price of $58.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when Burns James William sold 4,005 shares for $35.54 per share. The transaction valued at 142,338 led to the insider holds 18,650 shares of the business.
Jones Cecilia sold 2,275 shares of AGIO for $80,854 on Mar 03 ’25. The Chief Financial Officer now owns 21,843 shares after completing the transaction at $35.54 per share. On Mar 03 ’25, another insider, Milanova Tsveta, who serves as the Chief Commercial Officer of the company, sold 1,681 shares for $35.54 each. As a result, the insider received 59,743 and left with 22,892 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGIO now has a Market Capitalization of 1815143680 and an Enterprise Value of 978420544. As of this moment, Agios’s Price-to-Earnings (P/E) ratio for their current fiscal year is 2.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 49.73 while its Price-to-Book (P/B) ratio in mrq is 1.18. Its current Enterprise Value per Revenue stands at 26.808 whereas that against EBITDA is -2.329.
Stock Price History:
The Beta on a monthly basis for AGIO is 0.80, which has changed by 0.047619104 over the last 52 weeks, in comparison to a change of 0.08275449 over the same period for the S&P500. Over the past 52 weeks, AGIO has reached a high of $62.58, while it has fallen to a 52-week low of $27.14. The 50-Day Moving Average of the stock is -5.63%, while the 200-Day Moving Average is calculated to be -25.93%.
Shares Statistics:
It appears that AGIO traded 781.32K shares on average per day over the past three months and 638830 shares per day over the past ten days. A total of 57.16M shares are outstanding, with a floating share count of 55.17M. Insiders hold about 3.71% of the company’s shares, while institutions hold 106.79% stake in the company. Shares short for AGIO as of 1740700800 were 3939117 with a Short Ratio of 5.04, compared to 1738281600 on 5027013. Therefore, it implies a Short% of Shares Outstanding of 3939117 and a Short% of Float of 6.9699995.
